Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes

Anders L. Carlson, Jennifer L. Sherr, Dorothy I. Shulman, Satish K. Garg, Rodica Pop-Busui, Bruce W. Bode, David R. Lilenquist, Ron L. Brazg, Kevin B. Kaiserman, Mark S. Kipnes, James R. Thrasher, John H.Chip Reed, Robert H. Slover, Athena Philis-Tsimikas, Mark Christiansen, Benyamin Grosman, Anirban Roy, Melissa Vella, Richard A.M. Jonkers, Xiaoxiao ChenJohn Shin, Toni L. Cordero, Scott W. Lee, Andrew S. Rhinehart, Robert A. Vigersky

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)178-189
Number of pages12
JournalDiabetes Technology and Therapeutics
Volume24
Issue number3
DOIs
StatePublished - Mar 2022

ASJC Scopus Subject Areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Medical Laboratory Technology

Keywords

  • A1C
  • Adolescents
  • Adults
  • Advanced hybrid closed loop
  • Time-in-range
  • Type 1 diabetes

Cite this